{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:38:12Z","timestamp":1768685892609,"version":"3.49.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009620","name":"Gansu Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.critrevonc.2024.104495","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T23:50:04Z","timestamp":1725407404000},"page":"104495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?"],"prefix":"10.1016","volume":"204","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7764","key":"10.1016\/j.critrevonc.2024.104495_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","article-title":"TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection","volume":"571","author":"Alfei","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104495_bib2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/s41375-023-01911-2","article-title":"Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma","volume":"37","author":"Anagnostou","year":"2023","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104495_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104495_bib4","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41375-023-01885-1","article-title":"A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses","volume":"37","author":"Araujo-Ayala","year":"2023","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104495_bib5","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3324\/haematol.2022.282177","article-title":"The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy","volume":"108","author":"Arruga","year":"2023","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104495_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.gendis.2023.01.008","article-title":"Signaling pathways governing the behaviors of leukemia stem cells","volume":"11","author":"Azizidoost","year":"2024","journal-title":"Genes Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104495_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.immuni.2022.02.005","article-title":"Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8(+) T cell responses.","volume":"55","author":"Banta","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40164-023-00375-5","article-title":"Depletion of polyfunctional CD26(high)CD8(+) T cells repertoire in chronic lymphocytic leukemia","volume":"12","author":"Bozorgmehr","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104495_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.immuni.2020.09.010","article-title":"CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8(+) T Cells.","volume":"53","author":"Braun","year":"2020","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104495_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004794","article-title":"TIGIT blockade repolarizes AML-associated TIGIT(+) M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis","volume":"10","author":"Brauneck","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1930391","article-title":"Increased frequency of TIGIT(+)CD73-CD8(+) T cells with a TOX(+) TCF-1low profile in patients with newly diagnosed and relapsed AML","volume":"10","author":"Brauneck","year":"2021","journal-title":"Oncoimmunology"},{"issue":"23","key":"10.1016\/j.critrevonc.2024.104495_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312919","article-title":"Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML","volume":"22","author":"Brauneck","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2024.104495_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.763773","article-title":"Bone marrow-resident V\u03b41 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma","volume":"8","author":"Brauneck","year":"2021","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104495_bib14","first-page":"400","article-title":"[Comparison of the characteristics of NK cells after two different methods of expansion and observation of the clinical efficacy in patients who relapsed post allogeneic hematopoietic stem cell transplantation]","volume":"43","author":"Cao","year":"2022","journal-title":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1371399","article-title":"TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia","volume":"7","author":"Catakovic","year":"2017","journal-title":"Oncoimmunology"},{"issue":"20","key":"10.1016\/j.critrevonc.2024.104495_bib16","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1158\/1078-0432.CCR-20-0575","article-title":"IL15 stimulation with TIGIT blockade reverses CD155-mediated NK-Cell Dysfunction in Melanoma","volume":"26","author":"Chauvin","year":"2020","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104495_bib17","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1172\/JCI80445","article-title":"TIGIT and PD-1 impair tumor antigen-specific CD8\u207a T cells in melanoma patients.","volume":"125","author":"Chauvin","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104495_bib18","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41590-021-00965-7","article-title":"BATF regulates progenitor to cytolytic effector CD8(+) T cell transition during chronic viral infection","volume":"22","author":"Chen","year":"2021","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104495_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004711","article-title":"TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy","volume":"10","author":"Chiang","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"26","key":"10.1016\/j.critrevonc.2024.104495_bib20","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1182\/blood-2017-02-765685","article-title":"Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL","volume":"129","author":"Ding","year":"2017","journal-title":"Blood"},{"issue":"7865","key":"10.1016\/j.critrevonc.2024.104495_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","article-title":"TIM-3 restrains anti-tumour immunity by regulating inflammasome activation","volume":"595","author":"Dixon","year":"2021","journal-title":"Nature"},{"issue":"50","key":"10.1016\/j.critrevonc.2024.104495_bib22","doi-asserted-by":"crossref","first-page":"E11731","DOI":"10.1073\/pnas.1814052115","article-title":"CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1","volume":"115","author":"Du","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Pt A)","key":"10.1016\/j.critrevonc.2024.104495_bib23","article-title":"Simultaneous blockade of TIGIT and HIF-1\u03b1 induces synergistic anti-tumor effect and decreases the growth and development of cancer cells","volume":"101","author":"Fathi","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104495_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021303","article-title":"CD96 as a potential immune regulator in cancers","volume":"24","author":"Feng","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.critrevonc.2024.104495_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121157","article-title":"CD226 opposes TIGIT to disrupt Tregs in melanoma","volume":"3","author":"Fourcade","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.critrevonc.2024.104495_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbrc.2023.07.058","article-title":"Molecular and structural basis of TIGIT: Nectin-4 interaction, a recently discovered pathway crucial for cancer immunotherapy","volume":"677","author":"Ganguli","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2024.104495_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.699895","article-title":"TIGIT, the next step towards successful combination immune checkpoint therapy in cancer","volume":"12","author":"Ge","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib28","doi-asserted-by":"crossref","first-page":"2193528","DOI":"10.1080\/21645515.2023.2193528","article-title":"Update on combined immunotherapy for the treatment of advanced renal cell carcinoma","volume":"19","author":"Gebrael","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104495_bib29","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood.2022015522","article-title":"Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse","volume":"140","author":"Gournay","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104495_bib30","first-page":"751","article-title":"CD8+ T-cells Co-expressing PD-1 and TIGIT are highly frequent in chronic Lymphocytic leukemia","volume":"20","author":"Hajiasghar-Sharbaf","year":"2021","journal-title":"Iran. J. Allergy, Asthma, Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104495_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/cei.13407","article-title":"TIGIT as an emerging immune checkpoint","volume":"200","author":"Harjunp\u00e4\u00e4","year":"2020","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104495_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007502","article-title":"Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies","volume":"11","author":"Hasan","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104495_bib33","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.31557\/APJCP.2022.23.7.2225","article-title":"Combined Blockade Of PD-1 and TIGIT is not Sufficient to Improve the Function Of CD8+ T-Cells in Chronic Lymphocytic Leukemia","volume":"23","author":"Hatefi","year":"2022","journal-title":"Asian Pac. J. Cancer Prev.: APJCP"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104495_bib34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bbmt.2019.01.013","article-title":"Monitoring TIGIT\/DNAM-1 and PVR\/PVRL2 immune checkpoint expression levels in allogeneic stem cell transplantation for acute Myeloid Leukemia","volume":"25","author":"Hattori","year":"2019","journal-title":"Biol. Blood Marrow Transplant.\u00a0J. Am. Soc. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2024.104495_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1321126","article-title":"Higher TIGIT+ \u03b3\u03b4 T(CM) cells may predict poor prognosis in younger adult patients with non-acute promyelocytic AML","volume":"15","author":"Hou","year":"2024","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.critrevonc.2024.104495_bib36","doi-asserted-by":"crossref","first-page":"eade4186","DOI":"10.1126\/sciadv.ade4186","article-title":"PD-L1 methylation restricts PD-L1\/PD-1 interactions to control cancer immune surveillance","volume":"9","author":"Huang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.critrevonc.2024.104495_bib37","article-title":"Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16152-z","article-title":"B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12","volume":"12","author":"Hunter","year":"2022","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104495_bib39","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/bloodadvances.2022008854","article-title":"Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia","volume":"7","author":"Irani","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2024.104495_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.792609","article-title":"Gene expression analysis of the bone marrow microenvironment reveals distinct immunotypes in smoldering multiple myeloma associated to progression to symptomatic disease","volume":"12","author":"Isola","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104495_bib41","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-18-3107","article-title":"Eomes(+)T-bet(low) CD8(+) T cells are functionally impaired and are associated with poor clinical outcome in patients with acute Myeloid Leukemia.","volume":"79","author":"Jia","year":"2019","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/08820139.2020.1806868","article-title":"Higher TIGIT(+)CD226(-) \u03b3\u03b4 T cells in patients with acute Myeloid Leukemia","volume":"51","author":"Jin","year":"2022","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.critrevonc.2024.104495_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4612952","article-title":"Characteristic of TIGIT and DNAM-1 expression on Foxp3+ \u03b3\u03b4 T Cells in AML Patients","volume":"2020","author":"Jin","year":"2020","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.critrevonc.2024.104495_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1091782","article-title":"TIGIT: a promising target to overcome the barrier of immunotherapy in hematological malignancies","volume":"12","author":"Jin","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104495_bib45","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.1003081","article-title":"Cutting edge: TIGIT has T cell-intrinsic inhibitory functions","volume":"186","author":"Joller","year":"2011","journal-title":"J. Immunol. (Baltim., Md: 1950)"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104495_bib46","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI133353","article-title":"Minimal PD-1 expression in mouse and human NK cells under diverse conditions","volume":"130","author":"Judge","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104495_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3892\/ol.2021.13169","article-title":"CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia","volume":"23","author":"Kaito","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2024.104495_bib48","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2023.282915","article-title":"Immune checkpoint molecule DNAM-1\/CD112 axis is a novel target for NK-cell therapy in acute myeloid leukemia","author":"Kaito","year":"2023","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104495_bib49","first-page":"1107","article-title":"Immune checkpoint molecule DNAM-1\/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia","volume":"109","author":"Kaito","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2024.104495_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.745286","article-title":"Engineered Removal of PD-1 From the Surface of CD19 CAR-T cells results in increased activation and diminished survival","volume":"8","author":"Kalinin","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104495_bib51","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","article-title":"Precursor exhausted T cells: key to successful immunotherapy?","volume":"20","author":"Kallies","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib52","article-title":"MZF1 promotes tumour progression and resistance to anti-PD-L1 antibody treatment in hepatocellular carcinoma","volume":"6","author":"Kan","year":"2024","journal-title":"JHEP Rep.\u00a0Innov. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006120","article-title":"HTLV-1 bZIP factor enhances T-cell proliferation by impeding the suppressive signaling of co-inhibitory receptors","volume":"13","author":"Kinosada","year":"2017","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104495_bib54","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s12185-020-03047-w","article-title":"Correlation between increased immune checkpoint molecule expression and refractoriness to blinatumomab evaluated by longitudinal T cell analysis","volume":"113","author":"Kobayashi","year":"2021","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-019-0728-3","article-title":"Downregulation of CD73 associates with T cell exhaustion in AML patients","volume":"12","author":"Kong","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104495_bib56","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1158\/1078-0432.CCR-15-2626","article-title":"T-cell immunoglobulin and ITIM domain (TIGIT) Associates with CD8+ T-cell exhaustion and poor clinical outcome in AML patients","volume":"22","author":"Kong","year":"2016","journal-title":"Clin. Cancer Res.\u00a0Off. J. Am. Assoc. Cancer Res."},{"issue":"15","key":"10.1016\/j.critrevonc.2024.104495_bib57","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86850","article-title":"Autophagy-dependent regulatory T cells are critical for the control of graft-versus-host disease","volume":"1","author":"Le Texier","year":"2016","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104495_bib58","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/eji.201041136","article-title":"Vstm3 is a member of the CD28 family and an important modulator of T-cell function","volume":"41","author":"Levin","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"15","key":"10.1016\/j.critrevonc.2024.104495_bib59","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165723","article-title":"Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity","volume":"133","author":"Li","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"25","key":"10.1016\/j.critrevonc.2024.104495_bib60","doi-asserted-by":"crossref","first-page":"17647","DOI":"10.1074\/jbc.M114.572420","article-title":"T-cell immunoglobulin and ITIM domain (TIGIT) receptor\/poliovirus receptor (PVR) ligand engagement suppresses interferon-\u03b3 production of natural killer cells via \u03b2-arrestin 2-mediated negative signaling","volume":"289","author":"Li","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2024.104495_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.876689","article-title":"High expression of DC-STAMP gene predicts adverse outcomes in AML","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.critrevonc.2024.104495_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.740642","article-title":"Higher TOX genes expression is associated with poor overall survival for patients with acute Myeloid Leukemia","volume":"11","author":"Liang","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12964-022-00985-2","article-title":"Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes","volume":"20","author":"Liu","year":"2022","journal-title":"Cell Commun. Signal.\u00a0CCS"},{"key":"10.1016\/j.critrevonc.2024.104495_bib64","article-title":"Case Report: molecular and microenvironment change upon midostaurin treatment in mast cell leukemia at single-cell level","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104495_bib65","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/cdd.2012.141","article-title":"Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells","volume":"20","author":"Liu","year":"2013","journal-title":"Cell death Differ."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104495_bib66","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00262-021-02978-5","article-title":"Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis","volume":"71","author":"Liu","year":"2022","journal-title":"Cancer Immunol.\u00a0Immunother.: CII"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104495_bib67","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.1103627","article-title":"The TIGIT\/CD226 axis regulates human T cell function","volume":"188","author":"Lozano","year":"2012","journal-title":"J. Immunol. (Baltim.\u00a0Md.\u00a01950)"},{"issue":"17","key":"10.1016\/j.critrevonc.2024.104495_bib68","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1158\/1078-0432.CCR-19-3673","article-title":"Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT blockade in multiple Myeloma","volume":"26","author":"Lozano","year":"2020","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2024.104495_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109637","article-title":"OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma","volume":"251","author":"Lu","year":"2023","journal-title":"Clin. Immunol. (Orlando, Fla)"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib70","doi-asserted-by":"crossref","first-page":"2169531","DOI":"10.1080\/21645515.2023.2169531","article-title":"Immune checkpoint inhibitors as first-line therapy for non-small cell lung cancer: a systematic evaluation and meta-analysis","volume":"19","author":"Lu","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104495_bib71","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124427","article-title":"TIGIT signaling restores suppressor function of Th1 Tregs","volume":"4","author":"Lucca","year":"2019","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104495_bib72","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s10875-022-01279-5","article-title":"T and NK cells in IL2RG-deficient patient 50 years after hematopoietic stem cell transplantation","volume":"42","author":"Melsen","year":"2022","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib73","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104495_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054526","article-title":"Overexpression of potential markers of regulatory and exhausted CD8(+) T cells in the peripheral blood mononuclear cells of patients with B-Acute Lymphoblastic Leukemia","volume":"24","author":"Naghavi Alhosseini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104495_bib75","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.31557\/APJCP.2023.24.6.2171","article-title":"Relative expression of BATF and CD112 in PBMC of patients with chronic Lymphocytic Leukemia","volume":"24","author":"Najafi","year":"2023","journal-title":"Asian Pac. J. Cancer Prev.\u00a0APJCP"},{"key":"10.1016\/j.critrevonc.2024.104495_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.737880","article-title":"Bone Marrow Regulatory T Cells Are a unique population, supported by niche-specific cytokines and plasmacytoid dendritic cells, and required for chronic graft-versus-host disease control","volume":"9","author":"Nicholls","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"7425","key":"10.1016\/j.critrevonc.2024.104495_bib77","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11581","article-title":"Novel Foxo1-dependent transcriptional programs control T(reg) cell function.","volume":"491","author":"Ouyang","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib78","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1889822","article-title":"TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients","volume":"10","author":"Rakova","year":"2021","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104495_bib79","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm.2871","article-title":"Bat3 promotes T cell responses and autoimmunity by repressing Tim-3\u2013mediated cell death and exhaustion","volume":"18","author":"Rangachari","year":"2012","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104495_bib80","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104495_bib81","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells","volume":"103","author":"Satou","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2024.104495_bib82","article-title":"The effects of acute exercise and inflammation on immune function in early-stage prostate cancer","volume":"25","author":"Schauer","year":"2022","journal-title":"Brain\u00a0Behav.\u00a0Immun.\u00a0Health"},{"issue":"7764","key":"10.1016\/j.critrevonc.2024.104495_bib83","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"issue":"49","key":"10.1016\/j.critrevonc.2024.104495_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba7918","article-title":"TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells","volume":"5","author":"Sekine","year":"2020","journal-title":"Sci. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104495_bib85","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood.2023019875","article-title":"Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT","volume":"142","author":"Senjo","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2024.104495_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1280986","article-title":"Nonfucosylation of an anti-TIGIT antibody enhances Fc\u03b3R engagement, driving innate immune activation and antitumor activity","volume":"14","author":"Smith","year":"2023","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.critrevonc.2024.104495_bib87","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood.2020006345","article-title":"Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity","volume":"137","author":"Song","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2024.104495_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295293","article-title":"Response to therapy in Richter syndrome: a systematic review with meta-analysis of early clinical trials","volume":"14","author":"Sousa-Pimenta","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104495_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2023.1610914","article-title":"Characterization of the input material quality for the production of tisagenlecleucel by multiparameter flow cytometry and its relation to the clinical outcome","volume":"29","author":"\u0160tach","year":"2023","journal-title":"Pathol. Oncol. Res.: POR"},{"issue":"39","key":"10.1016\/j.critrevonc.2024.104495_bib90","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1038\/s41388-018-0288-y","article-title":"Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option","volume":"37","author":"Stamm","year":"2018","journal-title":"Oncogene"},{"issue":"42","key":"10.1016\/j.critrevonc.2024.104495_bib91","doi-asserted-by":"crossref","first-page":"17858","DOI":"10.1073\/pnas.0903474106","article-title":"The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity","volume":"106","author":"Stanietsky","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104495_bib92","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/bloodadvances.2021006195","article-title":"4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells","volume":"6","author":"Swatler","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2024.104495_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1296663","article-title":"Separation of GVL from GVHD -location, location, location","volume":"14","author":"Teshima","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104495_bib94","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/s41375-022-01649-3","article-title":"A phase two study of high dose blinatumomab in Richter's syndrome","volume":"36","author":"Thompson","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib95","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41598-023-27604-5","article-title":"CAR-tropic extracellular vesicles carry tumor-associated antigens and modulate CAR T cell functionality","volume":"13","author":"Ukrainskaya","year":"2023","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.critrevonc.2024.104495_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112828","article-title":"Preclinical evaluation of CRISPR-edited CAR-NK-92 cells for off-the-shelf treatment of AML and B-ALL","volume":"23","author":"Ure\u00f1a-Bail\u00e9n","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104495_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082171","article-title":"Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T cell subsets in patients with acute Myeloid Leukemia","volume":"12","author":"Valhondo","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2024.104495_bib98","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clim.2017.08.021","article-title":"CD8(+)T cells expressing both PD-1 and TIGIT but not CD226 are dysfunctional in acute myeloid leukemia (AML) patients","volume":"190","author":"Wang","year":"2018","journal-title":"Clin. Immunol. (Orlando, Fla)"},{"issue":"19","key":"10.1016\/j.critrevonc.2024.104495_bib99","article-title":"Single-cell RNA-Seq of T Cells in B-ALL patients reveals an exhausted subset with remarkable heterogeneity","volume":"8","author":"Wang","year":"2021","journal-title":"Adv. Sci. (Weinh.\u00a0Baden. Wurtt.\u00a0Ger.)"},{"key":"10.1016\/j.critrevonc.2024.104495_bib100","article-title":"Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Genet."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104495_bib101","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104495_bib102","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1158\/2159-8290.CD-21-1508","article-title":"Common trajectories of highly effective CD19-Specific CAR T cells identified by endogenous T-cell receptor lineages","volume":"12","author":"Wilson","year":"2022","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104495_bib103","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2018.02.023","article-title":"Early Reconstitution of NK and \u03b3\u03b4 T cells and its implication for the design of post-transplant immunotherapy","volume":"24","author":"de Witte","year":"2018","journal-title":"Biol. Blood Marrow Transplant.: J. Am. Soc. Blood Marrow Transplant."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104495_bib104","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.4049\/jimmunol.169.10.5392","article-title":"Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3","volume":"169","author":"Workman","year":"2002","journal-title":"J. Immunol. (Baltim.\u00a0Md.\u00a01950)"},{"key":"10.1016\/j.critrevonc.2024.104495_bib105","article-title":"Altered T follicular helper cell subsets and function in chronic Lymphocytic Leukemia","volume":"11","author":"Wu","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib106","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13046-021-02068-5","article-title":"Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy","volume":"40","author":"Wu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res.\u00a0CR"},{"issue":"13","key":"10.1016\/j.critrevonc.2024.104495_bib107","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1158\/0008-5472.CAN-13-2690","article-title":"LSECtin expressed on melanoma cells promotes tumor progression by inhibiting antitumor T-cell responses","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2024.104495_bib108","article-title":"PD-1 and TIGIT are highly co-expressed on CD8(+) T cells in AML patient bone Marrow","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02221-2","article-title":"FLT3-ITD transduces autonomous growth signals during its biosynthetic trafficking in acute myelogenous leukemia cells","volume":"11","author":"Yamawaki","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104495_bib110","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2326-6066.CIR-23-0722","article-title":"PVRL2 suppresses antitumor immunity through PVRIG- and TIGIT-independent Pathways","volume":"12","author":"Yang","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2024.104495_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1078118","article-title":"Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment","volume":"14","author":"Yao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104495_bib112","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9531549","article-title":"Increased Expression of TIGIT\/CD57 in peripheral blood\/bone marrow NK cells in patients with chronic Myeloid Leukemia","volume":"2020","author":"Yao","year":"2020","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005372","article-title":"HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT)","volume":"12","author":"Yasuma","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.critrevonc.2024.104495_bib114","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fmicb.2020.00979","article-title":"Strategies of Human T-Cell Leukemia Virus Type 1 for persistent infection: implications for leukemogenesis of adult T-cell Leukemia-Lymphoma","volume":"11","author":"Yasunaga","year":"2020","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104495_bib115","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1182\/blood.2021012519","article-title":"Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation","volume":"139","author":"You","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib116","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13075-023-03202-8","article-title":"TIGIT reverses IFN-\u03b1-promoted Th1-like Tregs via in-sequence effects dependent on STAT4","volume":"25","author":"Yu","year":"2023","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib117","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat. Immunol."},{"issue":"22","key":"10.1016\/j.critrevonc.2024.104495_bib118","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104495_bib119","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/ajco.13723","article-title":"Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT(+) NK cells may be related to poor outcome in acute myeloid leukemia","volume":"18","author":"Zeng","year":"2022","journal-title":"Asia-Pac. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104495_bib120","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41409-022-01619-4","article-title":"Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Zhang","year":"2022","journal-title":"Bone Marrow Transplant."},{"issue":"9 Pt B","key":"10.1016\/j.critrevonc.2024.104495_bib121","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1016\/j.bbadis.2018.06.022","article-title":"TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells","volume":"1864","author":"Zhang","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Dis."},{"key":"10.1016\/j.critrevonc.2024.104495_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111765","article-title":"Lactate acid promotes PD-1(+) Tregs accumulation in the bone marrow with high tumor burden of Acute myeloid leukemia.","volume":"130","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2024.104495_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.103958","article-title":"TIGIT expression is upregulated in T cells and causes T cell dysfunction independent of PD-1 and Tim-3 in adult B lineage acute lymphoblastic leukemia","volume":"344","author":"Zhang","year":"2019","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib124","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-022-01287-3","article-title":"Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant","volume":"15","author":"Zhao","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib125","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1038\/s41467-020-17991-y","article-title":"T cell exhaustion and a failure in antigen presentation drive resistance to the graft-versus-leukemia effect","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104495_bib126","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13045-017-0486-z","article-title":"Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia","volume":"10","author":"Zhu","year":"2017","journal-title":"J. Hematol. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824002385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824002385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T03:51:05Z","timestamp":1732938665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842824002385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":126,"alternative-id":["S1040842824002385"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104495","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104495"}}